Thu Nov 17, 2022 – 8:24 am EST
(Courageous Discourse) — Of all the great tension both doctors and patients have faced in the COVID-19 crisis is the lack of assurances on long-term safety of COVID-19 vaccines.
Americans were told these genetic products were brought through testing at “warp speed.” While that may be wonderful for the Starship Enterprise, warp speed should not be viewed as favorable in drug or vaccine development.
Observation time in research is very important to evaluate the emergence of problems, particularly for the long-lasting mRNA vaccines and their biologic product, the coronavirus spike protein. For a typical live-attenuated, killed, or antigen-based vaccine, the minimum period for safety observation in clinical development is two years. For genetic products which includes mRNA and adenoviral DNA, the minimum time is five years.
Now with mass indiscriminate vaccination, we have roughly two-thirds of adult populations who have received a novel vaccine and the progression of their baseline medical problems is the specific aim of research going forward at many centers.
Canney et al studied 1,105 patients who had stable glomerular kidney disease in 2020 before mRNA, and then followed them after receiving one or more of the
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
